Qlife publishes supplementary prospectus
Qlife Holding AB (“Qlife” or the “Company”) has prepared a supplementary prospectus (the “Supplementary Prospectus”) to the prospectus that was approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) and published on 6 April 2023 (the “Prospectus”).
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.
The Supplementary Prospectus has been prepared since Qlife, during the subscription period in the ongoing rights issue of units that was published through a press release on 16 February 2022 (the “Rights Issue”), has secured a top guarantee syndicate, in addition to the previously announced guarantee syndicate. The top guarantee syndicate amounts to approximately SEK 16.6 million and was announced through a press release on 13 April 2023. The press release is available on the Company’s website (www.qlifeholding.com).
The Supplementary Prospectus has been prepared in accordance with Article 23 in Regulation (EU) 2017/1129 of the European Parliament and of the Council (the “Prospectus Regulation”) and has today on 19 April 2023 been approved and registered by the Swedish Financial Supervisory Authority. The Supplementary Prospectus is part of, and shall in all respects be read together with, the Prospectus. The Prospectus and the Supplementary Prospectus (together the “Prospectuses”) are available on Qlife’s website (www.qlifeholding.com), G&W Fondkommission’s website (www.gwkapital.se), Aqurat Fondkommission’s website (www.aqurat.se) and will also be available on the Swedish Financial Supervisory Authority’s website (www.fi.se).
Investors who, prior to the publication of the Supplementary Prospectus, have notified or otherwise consented to subscribe for units in the Rights Issue are according to Article 23 in the Prospectus Regulation entitled to withdraw their notification or consent within two working days of the publication of the Supplementary Prospectus, i.e. until end of business 21 April 2023. Withdrawal must be made in writing to Aqurat Fondkommission AB, Matter: Qlife, P.O. Box 7461, SE-103 92 Stockholm, Sweden or via e-mail to email@example.com. Investors who have notified to subscribe for units through their bank/trustee should contact their bank/trustee regarding withdrawal. Notification that is not withdrawn within the specified time will remain binding and investors who wish to remain with their subscription of units do not have to take any measures.
For full terms and other information related to the Rights Issue, please refer to the Prospectuses.
G&W Fondkommission acts as financial advisor and Setterwalls Advokatbyrå AB acts as legal advisor to Qlife in connection with the Rights Issue. Aqurat Fondkommission AB acts as issuing agent in connection with the Rights Issue.